IRIDEA is a newly born University Spin off with a core business in drug discovery and development. The main focus of the company is the identification of small-molecule therapeutics with anti-angiogenic and anti-inflammatory properties
IRIDEA would satisfy unmet medical needs for therapeutic treatments of a variety of disorders characterized by background chronic inflammation states and/or aberrant angiogenesis, in turn due to dysregulated cell migration
IRIDEA exploits a consolidated know-how of the founders in the rational design, chemical synthesis and structural characterization of small-molecule biomimetic agents with pharmacological potential
Company name IRIDEA s.r.l.
VAT number 09693941214
Registration number 1050380